EssilorLuxottica to acquire South Korea’s PUcore optical division

EssilorLuxottica has signed an agreement to acquire all assets and business units of South Korean company PUcore related to the development, production, and commercialization of high-index monomers used in ophthalmic lens manufacturing.

The deal includes PUcore’s R&D center, manufacturing plant, and commercial subsidiary in South Korea, along with intellectual property rights covering chemical formulations and industrial processes.

“We are pleased to welcome PUcore’s optical division and its teams to our Group,” said Francesco Milleri, Chairman and CEO of EssilorLuxottica, and Paul du Saillant, Deputy CEO. “Aligned with our ongoing commitment to raising the bar in lens research, development, and manufacturing, this acquisition will expand our portfolio of patents, technologies, and expertise, while strengthening our upstream integration in the lens value chain. By innovating in the formulation and production of high-index monomers, we aim to further improve quality and sustainability across the supply chain, benefiting the entire industry.”

The transaction is expected to close by the end of 2025, pending regulatory approval and customary closing conditions.